释义 |
post-marketing surveillance
post-·mar·ket·ing sur·veil·lanceprocedure implemented after a drug has been licensed for public use, designed to provide information on use and on occurrence of side effects, adverse effects, etc.post-marketing surveillance Ongoing safety monitoring—e.g., in Phase-4 and Phase-5 studies—of marketed drugs.AcronymsSeePMS |